A case of hypoparathyroidism in a child with beta-thalassemia successfully treated with 1 alpha-hydroxy-vitamin D3.
A 13-year-old boy with homozygous beta-thalassemia who developed clinically manifest and biochemically proven hypoparathyroidism is described. The latter disease was attributed to hemosiderosis. Laboratory abnormalities were corrected after 1 alpha-hydroxy-vitamin D3 was administered.
D000293:Adolescent; D001803:Blood Transfusion; D004359:Drug Therapy, Combination; D006486:Hemosiderosis / Q000150:complications; D006720:Homozygote; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use*; D007011:Hypoparathyroidism / Q000188:drug therapy*; D008297:Male; D013789:Thalassemia / Q000150:complications* / Q000235:genetics; D013974:Thyroxine / Q000627:therapeutic use
D006887:Hydroxycholecalciferols; D013974:Thyroxine; C008088:alfacalcidol